Schizophrenia Trials in Houston, United States
Conditions / Schizophrenia / Houston, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
104 total trials for this combination
Showing top 10 of 104 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | RECRUITING | PHASE3 |
| NCT00528905 | Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia | COMPLETED | PHASE2 |
| NCT05211947 | A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study | TERMINATED | PHASE3 |
| NCT00396214 | Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients | TERMINATED | PHASE3 |
| NCT00034801 | Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia | COMPLETED | PHASE4 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT05859698 | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia | COMPLETED | PHASE4 |
| NCT01432444 | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole | COMPLETED | PHASE3 |
| NCT06229210 | Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder | RECRUITING | PHASE3 |
| NCT00102518 | Aripiprazole Open-Label, Safety and Tolerability Study | COMPLETED | PHASE3 |